Preemie Prep For Parents (P3): Home Antenatal Prematurity Education

Sponsor
Medical College of Wisconsin (Other)
Overall Status
Completed
CT.gov ID
NCT04093492
Collaborator
(none)
173
1
2
23.9
7.2

Study Details

Study Description

Brief Summary

The Preemie Prep for Parents (P3) mobile intervention will be tested in an outpatient population of pregnant women at risk of preterm birth and their partners. The study is an RCT comparing knowledge and preparedness for decision making between a group receiving the P3 texts and videos and a group receiving links to ACOG prematurity patient education handouts.

Condition or Disease Intervention/Treatment Phase
  • Other: Preemie Prep for Parents (P3) Outpatient Mobile Intervention
  • Other: ACOG links
N/A

Detailed Description

This is a randomized controlled study focused on an outpatient population of pregnant women at risk of preterm birth and their partners. The objective is to test the efficacy of the Preemie Prep for Parents (P3) intervention on prematurity knowledge and preparedness for decision making.

Participants are recruited from their obstetric clinic appointment between weeks 16 and 21, and randomized 1:1 to either the P3 intervention, or access to electronic ACOG handouts (active control). Any participating partners are assigned to the same arm as their pregnant partner. The participants in the P3 group will then receive a schedule of automated text messages, with video links, up to twice a day. These videos and messages are based on information relevant to their gestational age.

At study entry, participants will complete measures of their health literacy, anxiety, decision self-efficacy, and subjective global health. As pregnancy continues, questionnaires will be sent to participants at the start of their 25th, 30th, and 34th weeks. These questionnaires will include Prematurity Knowledge Questionnaires (specific to their gestational age), a Preparation for Decision Making scale, and an anxiety measure. At study completion, within two weeks of either preterm childbirth or completion of the 34 week questionnaire, participants will be asked to also complete the Educational-Aid Questionnaire.

Study Design

Study Type:
Interventional
Actual Enrollment :
173 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Preemie Prep For Parents (P3) Outpatient Mobile Intervention: Home Antenatal Prematurity Education
Actual Study Start Date :
Feb 3, 2020
Actual Primary Completion Date :
Sep 1, 2021
Actual Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Preemie Prep for Parents (P3) Outpatient Mobile Intervention

The P3 mobile intervention in its current form sends participants text messages according to a schedule based on their gestational age. These text messages contain links to short videos uploaded to the P3 site, focusing on topics related to preterm labor and premature infants.

Other: Preemie Prep for Parents (P3) Outpatient Mobile Intervention
The P3 mobile intervention sends participants text messages according to a schedule based on their gestational age. These text messages contain links to short videos uploaded to the P3 site, focusing on topics related to preterm labor and premature infants.

Active Comparator: ACOG links

Participants in the active control condition will receive links to patient education handouts about preterm birth provided by the American College of Obstetricians and Gynecologists.

Other: ACOG links
Participants in the active control condition will receive links to patient education handouts about preterm birth provided by the American College of Obstetricians and Gynecologists.

Outcome Measures

Primary Outcome Measures

  1. Prematurity Knowledge [Assessed at participant's 25th week of pregnancy.]

    Knowledge questionnaire developed by research team and tested through cognitive interviews, testing NICHD-recommended parental prematurity knowledge.

  2. Prematurity Knowledge [Assessed at participant's 30th week of pregnancy.]

    Knowledge questionnaire developed by research team and tested through cognitive interviews, testing NICHD-recommended parental prematurity knowledge.

  3. Prematurity Knowledge [Assessed at participant's 34th week of pregnancy.]

    Knowledge questionnaire developed by research team and tested through cognitive interviews, testing NICHD-recommended parental prematurity knowledge.

  4. Parental preparation for decision-making [Assessed at participant's 25th week of pregnancy.]

    Preparation for Decision Making Scale (Graham, O'Connor 1996, revised 2005). Scale ranges from a score of 10 to 50, with 50 demonstrating maximum preparedness to make a decision.

  5. Parental preparation for decision-making [Assessed at participant's 30th week of pregnancy.]

    Preparation for Decision Making Scale (Graham, O'Connor 1996, revised 2005). Scale ranges from a score of 10 to 50, with 50 demonstrating maximum preparedness to make a decision.

  6. Parental preparation for decision-making [Assessed at participant's 34th week of pregnancy.]

    Preparation for Decision Making Scale (Graham, O'Connor 1996, revised 2005). Scale ranges from a score of 10 to 50, with 50 demonstrating maximum preparedness to make a decision.

Secondary Outcome Measures

  1. Decision Self-Efficacy [Assessed at baseline and at 34 weeks of pregnancy.]

    Decision Self-Efficacy Scale (O'Connor, 1995). Scale ranges from a score of 0 to 44. A score of 44 would represent maximum decision self-efficacy.

  2. Anxiety [Assessed at baseline and participant's 25th week of pregnancy.]

    PROMIS Anxiety Computerized Adaptive Test (CAT). As a Computer Adaptive Test (CAT), not all participants receive the same number of questions, but may range between 4 and 12 questions. The number and selection of questions is dependent on the previous responses. An average US adult has a score of 50 with a standard deviation of 10; the higher that t-score, the greater amount of anxiety the respondent is reporting.

  3. Anxiety [Assessed at baseline and participant's 30th week of pregnancy.]

    PROMIS Anxiety Computerized Adaptive Test (CAT). As a Computer Adaptive Test (CAT), not all participants receive the same number of questions, but may range between 4 and 12 questions. The number and selection of questions is dependent on the previous responses. An average US adult has a score of 50 with a standard deviation of 10; the higher that t-score, the greater amount of anxiety the respondent is reporting.

  4. Anxiety [Assessed at baseline and participant's 34th week of pregnancy.]

    PROMIS Anxiety Computerized Adaptive Test (CAT). As a Computer Adaptive Test (CAT), not all participants receive the same number of questions, but may range between 4 and 12 questions. The number and selection of questions is dependent on the previous responses. An average US adult has a score of 50 with a standard deviation of 10; the higher that t-score, the greater amount of anxiety the respondent is reporting.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Pregnant woman or her partner

  • At risk for preterm birth, as indicated by: history of spontaneous preterm birth (during the 34th week or earlier), shortened cervical length, multiple gestation, fetal growth restriction, chronic hypertension, history of preeclampsia, and/or diabetes requiring medications.

  • Gestational age of 16-21 weeks at recruitment.

  • Owns a smartphone.

  • Able to speak English

Exclusion Criteria:

• Pregnancies with known significant birth defects.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Froedtert Hospital Milwaukee Wisconsin United States 53226

Sponsors and Collaborators

  • Medical College of Wisconsin

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mir A Basir, Associate Professor, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT04093492
Other Study ID Numbers:
  • PRO00033902
First Posted:
Sep 18, 2019
Last Update Posted:
Apr 19, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mir A Basir, Associate Professor, Medical College of Wisconsin
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 19, 2022